Targeting the SYVN1-EGFR axis: a breakthrough strategy for TKI-resistant NSCLC

ABSTRACT:

SUBMITTER: Xie X 

PROVIDER: S-EPMC12394631 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature